S&CO Inc’s Bristol-Myers Squibb BMY Stock Holding History

S&CO Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-279,270	Closed	-$14.3M	–	211
2023 Q4	$14.3M	Sell	279,270 -44,297	-14%	-$2.33M	1.1%	27
2023 Q3	$18.8M	Sell	323,567 -70,952	-18%	-$4.35M	1.54%	21
2023 Q2	$25.2M	Sell	394,519 -125	-0%	-$8.38K	2.03%	14
2023 Q1	$27.4M	Sell	394,644 -3,770	-0.9%	-$266K	2.32%	11
2022 Q4	$28.7M	Sell	398,414 -4,255	-1%	-$321K	2.51%	13
2022 Q3	$28.6M	Buy	402,669 +2,121	+0.5%	+$154K	2.58%	12
2022 Q2	$30.8M	Sell	400,548 -4,245	-1%	-$323K	2.59%	12
2022 Q1	$29.6M	Buy	404,793 +1,422	+0.4%	+$95.5K	2.08%	15
2021 Q4	$25.1M	Buy	403,371 +3,890	+1%	+$228K	1.78%	19
2021 Q3	$23.6M	Sell	399,481 -13,575	-3%	-$894K	1.84%	20
2021 Q2	$27.6M	Sell	413,056 -1,673	-0.4%	-$109K	2.16%	16
2021 Q1	$26.2M	Sell	414,729 -120	-0%	-$7.47K	2.2%	17
2020 Q4	$25.7M	Sell	414,849 -2,297	-0.6%	-$141K	2.3%	14
2020 Q3	$25.1M	Buy	417,146 +6,082	+1%	+$366K	2.51%	12
2020 Q2	$24.2M	Buy	411,064 +850	+0.2%	+$50.8K	2.66%	10
2020 Q1	$22.9M	Buy	410,214 +5,100	+1%	+$312K	3.05%	8
2019 Q4	$26M	Buy	405,114 +7,344	+2%	+$421K	2.71%	9
2019 Q3	$20.2M	Buy	397,770 +4,340	+1%	+$204K	2.23%	14
2019 Q2	$17.8M	Sell	393,430 -7,455	-2%	-$347K	1.96%	17
2019 Q1	$19.1M	Buy	400,885 +1,331	+0.3%	+$66.3K	2.13%	11
2018 Q4	$20.8M	Sell	399,554 -1,655	-0.4%	-$88.9K	2.63%	8
2018 Q3	$24.9M	Sell	401,209 -1,980	-0.5%	-$118K	2.79%	8
2018 Q2	$22.3M	Buy	403,189 +9,690	+2%	+$523K	2.68%	9
2018 Q1	$24.9M	Buy	393,499 +2,987	+0.8%	+$192K	3.13%	7
2017 Q4	$23.9M	Buy	390,512 +157	+0%	+$9.82K	2.97%	7
2017 Q3	$24.9M	Sell	390,355 -1,212	-0.3%	-$70.8K	3.18%	6
2017 Q2	$21.8M	Buy	391,567 +6,701	+2%	+$365K	2.88%	9
2017 Q1	$20.9M	Buy	384,866 +3,116	+0.8%	+$171K	2.85%	9
2016 Q4	$22.3M	Buy	381,750 +345,185	+944%	+$18.9M	3.23%	9
2016 Q3	$1.97M	Buy	36,565 +460	+1%	+$29.5K	0.3%	69
2016 Q2	$2.66M	Buy	36,105 +3,050	+9%	+$216K	0.41%	56
2016 Q1	$2.11M	Buy	33,055 +8,600	+35%	+$542K	0.34%	62
2015 Q4	$1.68M	Buy	24,455 +2,520	+11%	+$167K	0.28%	66
2015 Q3	$1.3M	Buy	21,935 +2,895	+15%	+$184K	0.22%	73
2015 Q2	$1.27M	Buy	19,040 +1,310	+7%	+$86.3K	0.19%	82
2015 Q1	$1.14M	Buy	17,730 +3,035	+21%	+$190K	0.16%	82
2014 Q4	$867K	Buy	14,695 +835	+6%	+$47.1K	0.13%	95
2014 Q3	$709K	Buy	13,860 +8,860	+177%	+$443K	0.11%	98
2014 Q2	$243K	Buy	5,000 +1,000	+25%	+$49.3K	0.03%	129
2014 Q1	$208K	Hold	4,000	–	–	0.03%	129
2013 Q4	$213K	Buy	+4,000	New	+$204K	0.04%	122

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

S&CO Inc's BMY Position: Q1 2024 in Review

S&CO Inc sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 279,270 shares — an estimated $14.3M sold.

S&CO Inc first reported a position in BMY in Q4 2013 and held it in 41 quarters. The position peaked at $30.8M in Q2 2022. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

S&CO Inc reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
S&CO Inc sold 279,270 Bristol-Myers Squibb shares in Q1 2024, an estimated $14.3M.
S&CO Inc first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 41 quarters.
S&CO Inc's Bristol-Myers Squibb position peaked at $30.8M in Q2 2022.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on S&CO Inc's 13F filing for Q1 2024, filed 9 May 2024.